When it comes to life science marketing, most companies fall into one of two traps:
They either blast generic cold emails and get ignored, or they spend hours crafting hyper-personalized messages that still disappear into spam folders.
We’ve seen it across dozens of campaigns in the biopharma, CRO, and CDMO space. It’s not that your messaging is bad—it’s that your channel is broken.
Over the past 12 months, our team at Accel Bio has booked 250+ meetings with pharma decision-makers using a strategy that’s equal parts targeting, persistent execution, and utilizing the right channels to reach the right prospects.
In this post, we’ll break down the system, the scripts, the tools—and the cold, hard numbers behind it. Whether you’re a marketing leader at a life science company or a business development director looking to fill your team’s pipeline, this framework can work for you.
Why Cold Calling Still Works for Life Science Marketing
Yes, we cold call.
Cold calling works because no one wants to do it—so the few who do, win.
In a space where decision-makers are inundated with email, the phone cuts through the noise. While email open rates are sinking and LinkedIn DMs are increasingly ignored, a direct call still gets attention—especially when timed right.
Phone outreach allows you to:
- Personalize the conversation in real time
- Handle objections immediately
- Secure next steps on the spot
The result? Real conversations with real decision-makers—something most marketing channels can’t promise anymore.
💡 Want help doing the cold calling your competitors are avoiding?
👉 Book a quick call with our team and we’ll walk you through how it works.